Literature DB >> 31139680

Cognitive deficits in adult m.3243A>G- and m.8344A>G-related mitochondrial disease: importance of correcting for baseline intellectual ability.

Heather L Moore1,2, Thomas Kelly3, Alexandra Bright1, Robert H Field1, Andrew M Schaefer1, Alasdair P Blain1, Robert W Taylor1, Robert McFarland1, Doug M Turnbull1, Gráinne S Gorman1.   

Abstract

OBJECTIVE: To determine the cognitive profile of adult patients with mitochondrial disease, and the effect of disease severity on cognition.
METHODS: Using a prospective case-control design, we compared cognition of patients to normative data and to matched controls, assessed three times over 18 months. Forty-nine patients with m.3243A>G (N = 36) and m.8344A>G (N = 13) mtDNA mutations and 32 controls, matched by age (±5 years) and premorbid cognition (±10 WTAR FSIQ points), participated. Participants completed neuropsychological assessments of general cognition (WAIS-IV), executive function (D-KEFS), and memory (WMS-IV). Potential predictors of cognition were explored.
RESULTS: Patients show mild-to-moderate premorbid cognitive impairment, but substantial impairment in current general cognition and distinct domains, including verbal comprehension, perceptual reasoning, working memory, processing speed, and memory retrieval. Executive dysfunction may be caused by slower decision-making. Patients performed worse than controls, except on memory tasks, indicating intact memory, when premorbid cognition is controlled for. Premorbid cognition and disease severity were consistent predictors of cognition in patients; however, cognitive decline appears slow and is unlikely in the short-term, when other disease-specific factors remain stable.
INTERPRETATION: Patients should be monitored to facilitate early identification of a complex profile of cognitive deficits and individuals with higher disease burden should be followed up more closely. On development of cognitive difficulties, appropriate compensatory strategies should be determined through in-depth assessment. Using strategies such as slower presentation of information, multiple modes of presentation, active discussion to aid understanding and decision-making, and use of memory aids, may ameliorate difficulties.

Entities:  

Mesh:

Year:  2019        PMID: 31139680      PMCID: PMC6529924          DOI: 10.1002/acn3.736

Source DB:  PubMed          Journal:  Ann Clin Transl Neurol        ISSN: 2328-9503            Impact factor:   4.511


  24 in total

1.  The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval.

Authors:  J R Crawford; I J Deary; J Starr; L J Whalley
Journal:  Psychol Med       Date:  2001-04       Impact factor: 7.723

2.  The course of vision disturbances in a patient with the MELAS syndrome.

Authors:  Maria Pachalska; Salvatore DiMauro; Maria Formińska-Kapuścik; Henryk Kurzbauer; Jan Talar; Bruce Duncan MacQueen; Iwona Pawlicka; Irena Jeleńska-Szyguła
Journal:  Med Sci Monit       Date:  2002-02

3.  National Adult Reading Test performance in established dementia.

Authors:  R Taylor
Journal:  Arch Gerontol Geriatr       Date:  1999 Nov-Dec       Impact factor: 3.250

4.  Pronunciation of irregular words is preserved in dementia, validating premorbid IQ estimation.

Authors:  B McGurn; J M Starr; J A Topfer; A Pattie; M C Whiteman; H A Lemmon; L J Whalley; I J Deary
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

5.  Electrophysiological analysis of cognitive slowing in subjects with mitochondrial encephalomyopathy.

Authors:  R Montirosso; D Brambilla; G Felisari; F Sclaunich; E Filipponi; U Pozzoli; N Bresolin
Journal:  J Neurol Sci       Date:  2002-02-15       Impact factor: 3.181

6.  Focal cognitive impairment in mitochondrial encephalomyopathies: a neuropsychological and neuroimaging study.

Authors:  A C Turconi; R Benti; E Castelli; S Pochintesta; G Felisari; G Comi; C Gagliardi; L Del Piccolo; N Bresolin
Journal:  J Neurol Sci       Date:  1999-11-15       Impact factor: 3.181

7.  Progressive decline in NART score with increasing dementia severity.

Authors:  J Cockburn; J Keene; T Hope; P Smith
Journal:  J Clin Exp Neuropsychol       Date:  2000-08       Impact factor: 2.475

8.  A 3-year clinical follow-up of adult patients with 3243A>G in mitochondrial DNA.

Authors:  K A M Majamaa-Voltti; S Winqvist; A M Remes; U Tolonen; J Pyhtinen; S Uimonen; M Kärppä; M Sorri; K Peuhkurinen; K Majamaa
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

9.  Cerebral lactic acidosis correlates with neurological impairment in MELAS.

Authors:  P Kaufmann; D C Shungu; M C Sano; S Jhung; K Engelstad; E Mitsis; X Mao; S Shanske; M Hirano; S DiMauro; D C De Vivo
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

10.  Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.

Authors:  Simone Bosbach; Cornelia Kornblum; Rolf Schröder; Michael Wagner
Journal:  Brain       Date:  2003-05       Impact factor: 13.501

View more
  6 in total

1.  A conceptual disease model for quality of life in mitochondrial disease.

Authors:  Kim F E van de Loo; Nander T van Zeijl; Mirian C H Janssen; Christianne M Verhaak; José A E Custers
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

2.  Mitochondrial Functions, Cognition, and the Evolution of Intelligence: Reply to Commentaries and Moving Forward.

Authors:  David C Geary
Journal:  J Intell       Date:  2020-12-08

3.  Neurodegenerative and functional signatures of the cerebellar cortex in m.3243A > G patients.

Authors:  Roy A M Haast; Irenaeus F M De Coo; Dimo Ivanov; Ali R Khan; Jacobus F A Jansen; Hubert J M Smeets; Kâmil Uludağ
Journal:  Brain Commun       Date:  2022-02-03

4.  Cognitive functioning and mental health in children with a primary mitochondrial disease.

Authors:  Kim F E van de Loo; José A E Custers; Lonneke de Boer; Marloes van Lieshout; Maaike C de Vries; Mirian C H Janssen; Christianne M Verhaak
Journal:  Orphanet J Rare Dis       Date:  2022-10-01       Impact factor: 4.303

5.  Systematic review of cognitive deficits in adult mitochondrial disease.

Authors:  H L Moore; A P Blain; D M Turnbull; G S Gorman
Journal:  Eur J Neurol       Date:  2019-10-22       Impact factor: 6.288

Review 6.  Mitochondrial Functioning and the Relations among Health, Cognition, and Aging: Where Cell Biology Meets Cognitive Science.

Authors:  David C Geary
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.